Company Filing History:
Years Active: 2002
Title: The Innovative Contributions of Anne-Marie Eva Fernande Delisse
Introduction
Anne-Marie Eva Fernande Delisse is a notable inventor based in Gosselies, Belgium. She has made significant contributions to the field of biotechnology, particularly in the development of vaccines. Her work focuses on addressing critical health issues through innovative solutions.
Latest Patents
Delisse holds a patent for a recombinant papillomavirus vaccine and method for production and treatment. This invention relates to fusion proteins that comprise a protein or part of a protein providing T helper epitopes and an antigen from a human papillomavirus. Specifically, the invention includes fusion proteins comprising an E6 or E7 protein from HPV strains 16 or 18 linked to protein D from B. The vaccine compositions developed through this invention are useful in the treatment or prophylaxis of human papilloma-induced tumors. She has 1 patent to her name.
Career Highlights
Delisse has worked with SmithKline Beecham Biologicals S.A., where she has contributed to groundbreaking research in vaccine development. Her expertise in biotechnology has positioned her as a key player in her field.
Collaborations
Throughout her career, Delisse has collaborated with esteemed colleagues, including Claudine Bruck and Teresa Cabezon Silva. These partnerships have enhanced her research and contributed to the advancement of vaccine technology.
Conclusion
Anne-Marie Eva Fernande Delisse's innovative work in vaccine development exemplifies her commitment to improving public health. Her contributions continue to have a lasting impact on the field of biotechnology.